Basic Information
Basic information for FTX-268-16aa-2
Peptide Name FTX-268-16aa-2
Genome Position chrX:74202674-74202721[-]
Species Human
Peptide Sequence MDFREFLVEDSKSHLS
Peptide Length 16
Unique No (FTX-210-16aa-2,FTX-218-16aa,FTX-223-16aa,FTX-224-16aa,FTX-228-16aa-1,FTX-229-16aa-2,FTX-231-16aa-2,FTX-233-16aa-2,FTX-236-16aa-2,FTX-238-16aa-1,FTX-241-16aa-2,FTX-245-16aa-2,FTX-257-16aa-2,FTX-261-16aa-1,FTX-264-16aa-1,FTX-265-16aa-2,FTX-266-16aa-4)
Grand Average of Hydropathicity -0.5438
Relative Molecular Mass 2210.36
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000669263;FTX-268
Transcript Length 2488
Coding Ability 0.502
DNA Sequence Corresponding to Peptide ATGGACTTCAGAGAGTTCTTGGTAGAAGACTCAAAGAGCCACCTGTCA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :